Dr. Gregory M Tiao
Claim this profileStudies Hepatoblastoma
Studies Skin Cancer
1 reported clinical trial
3 drugs studied
Area of expertise
1Hepatoblastoma
SMARCB1 positive
SMARCB1 negative
2Skin Cancer
SMARCB1 positive
SMARCB1 negative
More about Gregory M Tiao
Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Gregory M Tiao has experience with
- Cisplatin
- Doxorubicin, Fluorouracil, Vincristine Sulfate, Etoposide, Irinotecan, Sorafenib, Gemcitabine, Oxaliplatin, Carboplatin
- Resection
Breakdown of trials Gregory M Tiao has run
Hepatoblastoma
Skin Cancer
Liver Cancer
Hepatocellular Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gregory M Tiao specialize in?
Gregory M Tiao focuses on Hepatoblastoma and Skin Cancer. In particular, much of their work with Hepatoblastoma has involved SMARCB1 positive patients, or patients who are SMARCB1 negative.
Is Gregory M Tiao currently recruiting for clinical trials?
No, Gregory M Tiao is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Gregory M Tiao has studied deeply?
Yes, Gregory M Tiao has studied treatments such as Cisplatin, Doxorubicin, Fluorouracil, Vincristine Sulfate, Etoposide, Irinotecan, Sorafenib, Gemcitabine, Oxaliplatin, Carboplatin, Resection.
What is the best way to schedule an appointment with Gregory M Tiao?
Apply for one of the trials that Gregory M Tiao is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.